据悉，目标公司主要从事投资控股业务，并全资拥有目标外商独资企业，该企业是在中国成立的全外资企业，主要从事制造和销售制药用水和蒸汽设备，并提供相关的技术服务。AUSTAR Life Science Technology (06118) announced that on December 16, 2024, its wholly-owned subsidiary...
According to Zhito Finance APP, AUSTAR Life Science Technology (06118) announced that on December 16, 2024, its wholly-owned subsidiary AUSTAR Equipment Co., Ltd. completed the acquisition of 51% equity of STERIS Mauritius Limited in STERIS AUSTAR Pharmaceutical Equipment Co., Ltd. for a price of 1.515 million USD.
Prior to the signing of the transaction agreement, the target company was owned 51% by the seller and 49% by the buyer. After completion, the target company will be wholly owned by the buyer.
It is understood that the target company is mainly engaged in investment holding business and wholly owns a foreign-funded enterprise that was established in China, primarily engaged in the manufacturing and sales of pharmaceutical water and steam equipment, and providing related technical services.
In relation to the acquisition, the group also signed a technical and trademark licensing agreement with STERIS, under which the group is authorized to produce products related to Finn-Aqua owned by STERIS and exclusively continue to provide high-quality products to customers in the Chinese market under the STERIS brand, and non-exclusively in several other non-restricted areas. This will positively respond to the current market situation, aiming to fully utilize the technical advantages and market recognition of the target company and STERIS in the Industry. This will enhance the group's market competitiveness, invigorate the group's future development, and take an important step towards the group's strategic development.
Considering the group’s Business strategy, the Directors believe that through the acquisition, the group will be able to integrate resources, improve efficiency, thereby enhancing overall market coverage and strengthening the group's market penetration capability in collaboration with STERIS around the Global, while better utilizing the competitive advantages and financial performance of the target company, promoting the group's medium to long-term development.
